Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson’s disease

BACKGROUND: Depressive symptoms are common in patients with Parkinson’s disease and depression is a significant predictor of functional impairment, reduced quality of life and general well-being in Parkinson's disease. Despite the high prevalence of depression, evidence on the effectiveness and...

Descripción completa

Detalles Bibliográficos
Autores principales: Schrag, A, Carroll, C, Duncan, G, Molloy, S, Grover, L, Hunter, R, Brown, R, Freemantle, N, Whipps, J, Serfaty, M. A, Lewis, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743717/
https://www.ncbi.nlm.nih.gov/pubmed/36510237
http://dx.doi.org/10.1186/s12883-022-02988-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743717/
https://www.ncbi.nlm.nih.gov/pubmed/36510237
http://dx.doi.org/10.1186/s12883-022-02988-5

Ejemplares similares